We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+0.21%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$5.18B
AUM Growth
-$490M
Cap. Flow
-$405M
Cap. Flow %
-7.82%
Top 10 Hldgs %
64.56%
Holding
133
New
7
Increased
36
Reduced
60
Closed
9

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$164M
2
FRC
First Republic Bank
FRC
+$32.8M
3
C icon
Citigroup
C
+$32.7M
4
TSM icon
TSMC
TSM
+$16.8M
5
CLVS
Clovis Oncology, Inc.
CLVS
+$11.5M

Top Sells

Rank Stock Value
1
DG icon
Dollar General
DG
+$269M
2
MCK icon
McKesson
MCK
+$226M
3
V icon
Visa
V
+$95.7M
4
CVS icon
CVS Health
CVS
+$17.5M
5
META icon
Meta Platforms (Facebook)
META
+$14.5M

Sector Composition

Rank Sector Weight
1 Financials 26.52%
2 Healthcare 19.99%
3 Consumer Discretionary 17.87%
4 Communication Services 13.4%
5 Consumer Staples 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBYI icon
101
Puma Biotechnology
PBYI
$403M
$921K 0.02%
30,000
– –
JPM icon
102
JPMorgan Chase
JPM
$926B
$888K 0.02%
10,300
– –
HIND
103
Vyome Holdings
HIND
$14.3M
– –
0
– –
ADPT
104
DELISTED
Adeptus Health Inc
ADPT
$817K 0.02%
107,000
– –
WP
105
DELISTED
Worldpay, Inc.
WP
$680K 0.01%
11,400
– –
DG icon
106
Dollar General
DG
$28.3B
$630K 0.01%
8,500
-3,690,584
-100% -$269M
MDT icon
107
Medtronic
MDT
$112B
$556K 0.01%
7,800
– –
ZVRA icon
108
Zevra Therapeutics
ZVRA
$576M
$487K 0.01%
10,313
– –
VRTX icon
109
Vertex Pharmaceuticals
VRTX
$124B
$442K 0.01%
6,006
-14,794
-71% -$1.2M
IONS icon
110
Ionis Pharmaceuticals
IONS
$8.98B
$287K 0.01%
6,000
-31,100
-84% -$1.23M
RDUS
111
DELISTED
Radius Health, Inc.
RDUS
$280K 0.01%
7,354
-10,276
-58% -$489K
BAP icon
112
Credicorp
BAP
$30.7B
$267K 0.01%
1,691
+291
+21% +$44.6K
ISEE
113
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$256K ﹤0.01%
53,000
– –
ACAD icon
114
Acadia Pharmaceuticals
ACAD
$4.51B
$236K ﹤0.01%
8,184
-12,206
-60% -$323K
INNL
115
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$204K ﹤0.01%
295,184
– –
BLUE
116
DELISTED
bluebird bio
BLUE
$199K ﹤0.01%
249
-369
-60% -$293K
ASXC
117
DELISTED
Asensus Surgical, Inc.
ASXC
$195K ﹤0.01%
11,538
– –
LXRX icon
118
Lexicon Pharmaceuticals
LXRX
$1.04B
$158K ﹤0.01%
11,397
-11,203
-50% -$180K
ICPT
119
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$156K ﹤0.01%
1,439
-2,361
-62% -$281K
KERX
120
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$152K ﹤0.01%
26,000
-490,110
-95% -$2.68M
XLRN
121
DELISTED
Acceleron Pharma
XLRN
$136K ﹤0.01%
5,320
-11,080
-68% -$351K
REGN icon
122
Regeneron Pharmaceuticals
REGN
$72.9B
$128K ﹤0.01%
350
-3,100
-90% -$1.18M
KPTI icon
123
Karyopharm Therapeutics
KPTI
$157M
$122K ﹤0.01%
+867
New +$117K
SRPT icon
124
Sarepta Therapeutics
SRPT
$1.66B
$91K ﹤0.01%
+3,304
New +$133K
COO icon
125
Cooper Companies
COO
$14.1B
– –
-52,000
Closed -$2.33M
2 3 4
5
6

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q4 2016 Portfolio in Review

As of Q4 2016, C WorldWide Group held 133 positions worth $5.18B, down 8.6% from $5.67B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

C WorldWide Group withdrew a net $405M in Q4 2016, closing 9 positions and reducing 60 holdings. Its most notable exit was McKesson, an estimated $226M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, C WorldWide Group opened a new position in Philip Morris worth $162M.

  • C WorldWide Group's largest Q4 2016 buy was Philip Morris: 1,771,417 shares worth $162M.
  • C WorldWide Group added most to First Republic Bank in Q4 2016, an estimated $32.8M increase.
  • C WorldWide Group's biggest Q4 2016 reduction was Dollar General, cutting an estimated $269M.
  • C WorldWide Group fully exited McKesson in Q4 2016, selling an estimated $226M.
  • C WorldWide Group's ten largest holdings make up 65% of its $5.18B portfolio in Q4 2016.
  • C WorldWide Group opened 7 new positions and closed 9 in Q4 2016.
  • C WorldWide Group's portfolio value fell 8.6% quarter-over-quarter to $5.18B.

Based on C WorldWide Group's 13F filing for Q4 2016, filed 6 Feb 2017.